Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum

Share Name	Share Symbol	Market	Type
Cantel Medical Corp.	NYSE:CMN	NYSE	Common Stock

Share Name

Share Symbol

Market

Type

Cantel Medical Corp.

NYSE:CMN

NYSE

Common Stock

	Price Change	% Change	Share Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	81.14				0	01:00:00

Price Change

% Change

Share Price

High Price

Low Price

Open Price

Shares Traded

Last Trade

0.00

0.00%

81.14

01:00:00

Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum

05/11/2009 1:30pm

PR Newswire (US)

Cantel (NYSE:CMN)
Historical Stock Chart

From Jun 2019 to Jun 2024

LITTLE FALLS, N.J., Nov. 5 /PRNewswire-FirstCall/ -- CANTEL MEDICAL CORP. (NYSE:CMN) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the Sidoti & Company, LLC Emerging Growth Research Institutional Investor Forum. The formal presentation is scheduled for 9:05 AM ET on Friday, November 20, 2009 at the Grand Hyatt New York, with a Q & A session immediately following the presentation. In addition, Mr. Krakauer and Seth R. Segel, Executive Vice President, will be available for separate one-on-one meetings during the day. The presentation will be available on the Investor Relations section of the Company's website: http://www.cantelmedical.com/. Cantel Medical Corp. (NYSE:CMN) is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens. For more information, please visit http://www.cantelmedical.com/. DATASOURCE: Cantel Medical Corp. CONTACT: Andrew A. Krakauer, President & CEO, Cantel Medical Corp., Phone: +1-973-890-7220, or Richard E. Moyer, Cameron Associates, Inc., Phone: +1-212-554-5466, Web Site: http://www.cantelmedical.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

CMN Cantel Medical Corp.